Newsletter Archive
-
05.08.24 -- Where Are They Now? SQZ Biotech
5/8/2024
05/08/24 Life Science Leader Newsletter
-
05.06.24 -- Considerations For Direct-To-Patient Offerings
5/6/2024
05/06/24 Life Science Leader Newsletter
-
05.03.24 -- Reviva Pharma's Novel Funding Approach
5/3/2024
05/03/24 Life Science Leader Newsletter
-
05.03.24 -- Listen now: Precision Drug Delivery, Clinical Trial Progress for Parkinson's, Funding Alzheimer's Tx, and more.
5/3/2024
05/03/24 Life Science Leader Newsletter
-
05.01.24 -- What's Behind Biotech Contract Manufacturing Growth
5/1/2024
05/01/24 Life Science Leader Newsletter
-
04.30.24 -- Ocular Drug Delivery Systems: The Advantages Of Nanoparticles
4/30/2024
04/30/24 Life Science Leader Newsletter
-
04.29.24 -- Companies To Watch: OSE Immunotherapeutics
4/29/2024
04/29/24 Life Science Leader Newsletter
-
04.26.24 -- Five Key Attributes For Biotech Growth
4/26/2024
04/26/24 Life Science Leader Newsletter
-
04.24.24 -- Understanding Changes In Product Liability Law
4/24/2024
04/24/24 Life Science Leader Newsletter
-
04.24.24 -- Maximizing Biologics Potential Through Integrated Services For Faster Timelines
4/24/2024
04/24/24 Life Science Leader Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more